Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01736085 · ClinicalTrials.gov registry record · Phase 3
Providing Free Nicotine Patches to Quitline Smokers
A Phase 3 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 3
- Development phase
- 3,706
- Enrollment target
NCT01736085: Completed Phase 3 study, sponsored by University of California, San Diego.
NCT01736085 is a Phase 3 study that has completed, run by University of California, San Diego. The registered enrollment target is 3,706 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (380% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01736085, a Phase 3 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 3,706 participants
- Enrollment target
Study Summary
The California Smokers' Helpline will conduct a 3 X 2 (nicotine patch by counseling condition) randomized trial to test the provision of nicotine patches to help smokers calling a telephone quitline. The study assesses one factor related to nicotine patches with 3 levels: sending patches directly from the Helpline, providing vouchers that can be redeemed for patches, and usual care. A second factor is counseling plus materials versus materials only. This proposed study has the following specific aims: 1. To demonstrate that a voucher for free nicotine patches will increase the quit rate for smokers who do not have access to free nicotine replacement therapy (NRT) 2. To demonstrate that sending patches directly from a quitline would outperform sending vouchers for free NRT, since the vouchers impose an additional barrier to those who want to quit 3. To determine the effect of telephone counseling in the context of nicotine patch distribution and if any interaction effects exist between counseling and patch conditions
Primary Outcome
At seven months post enrollment we will conduct a brief telephone survey to assess smoking status. The information obtained will allow us to determine six month prolonged abstinence rates.
Interventions
- BEHAVIORAL Telephone counseling
- DRUG Nicotine patches
- BEHAVIORAL Voucher
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,706 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-11 |
| Phase | Phase 3 |
What the finished NCT01736085 record still lists
NCT01736085 is an interventional study that assigns participants to a tested intervention. Its 3,706 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (380% higher).
The record links to 0 conditions, and to 3 interventions - of which Telephone counseling is the first listed.
NCT01736085 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01736085 about?
NCT01736085 is a clinical study titled "Providing Free Nicotine Patches to Quitline Smokers". The California Smokers' Helpline will conduct a 3 X 2 (nicotine patch by counseling condition) randomized trial to test the provision of nicotine patches to help smokers calling a telephone quitline. The study assesses one factor related to nicotine patches with 3 levels: sending patches directly fr...
What is the current status of trial NCT01736085?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,706 participants. The study started on 2013-04. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01736085?
The interventions under investigation include: Telephone counseling (BEHAVIORAL), Nicotine patches (DRUG), Voucher (BEHAVIORAL).
Who is sponsoring clinical trial NCT01736085?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01736085's enrollment target sits among peer trials
3,706 66th of 2000 higher than 1,935 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06076304 · 3,720 participants · Phase 4
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
- NCT06401863 · 3,691 participants · NA
Shared Decision for Drug Interactions in Oral Anticoagulation
- NCT06784960 · 3,689 participants · NA
Communication Strategies to Increase HPV Vaccination Intention
- NCT06058377 · 3,680 participants · Phase 3
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia